OTC Medicines

Browse OTC Medicines Content

CHPA is writing to request that FDA exercise its enforcement discretion and not take enforcement action against companies choosing to include a warning related to pregnancy on monograph product labels.

Jun 2, 2021

CHPA launched a new podcast – CHPA Chat – providing stories and insights from staff, industry leaders, academics, and healthcare providers about the trends and issues facing the consumer healthcare space.

May 3, 2021

In a new letter, ACI and CHPA call on FDA to withdraw its temporary guidance for the manufacturing of alcohol-based hand sanitizer products.

Apr 29, 2021

The American Cleaning Institute (ACI) and the Consumer Healthcare Products Association (CHPA) request that FDA withdraw its Guidance for Industry: Temporary Policy for Preparation of Certain Alcohol-Based Hand Sanitizer Products During the Public Health Emergency (COVID-19).

Apr 28, 2021

CHPA congratulates Patrizia Cavazzoni on her recent appointment as director of FDA’s Center for Drug Evaluation and Research (CDER).

Apr 13, 2021

CHPA congratulates Xavier Becerra upon his confirmation by the U.S. Senate as Secretary of the Department of Health & Human Services (HHS).

Mar 18, 2021

In a major victory for consumer health, today Mississippi has repealed an 11-year-old law that banned over-the-counter (OTC) sales of certain medicines for colds and allergies containing the decongestant pseudoephedrine (PSE).

Mar 17, 2021

The new law returns PSE to OTC status allowing consumers to purchase 3.6 grams of PSE per day, up to 7.2 grams per month.

Mar 17, 2021

CHPA welcomes Church & Dwight, Co., Inc., Bridges Consumer Healthcare, and Rhinomed Inc. as its newest manufacturer members of the association.

Feb 22, 2021

Filter Results